WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Study overturns century-old rule of pharmacology

Details
Research
27 August 2008
One of pharmacology's oldest underlying principles looks set to be overturned. New findings from chemists at the UK's University of Warwick appear to contradict the century-old 'Overton's Rule', which sets out how fast chemicals, such as medicines, can cross cell walls. The findings have major implications for drug development.
Read more ...

Manhattan Research's ePharma Physician® study ranks the top online journals by physician visitation

Details
Research
22 August 2008
Manhattan ResearchThe New England Journal of Medicine and American Family Physician rank as top online medical journals among U.S. primary care physicians, according to the just released ePharma Physician® v8.0 study by pharmaceutical and healthcare market research company Manhattan Research.
Read more ...

Abcam and Transinsight Collaborate in the Area of Semantic Search Technologies

Details
Research
15 August 2008
Abcam, a bioscience company specialising in the supply of antibodies from a web-based catalogue and Transinsight, a specialist in semantic search technologies announced a collaboration in the field of protein information quality control using bioinformatics workflows.
Read more ...

Physicians Expect to Shift More Time to Online Professional Resources in the Coming Years

Details
Research
14 August 2008
Manhattan ResearchPhysicians report that they will shift a significant amount of time currently devoted to offline professional sources to their online counterparts in the coming years, according to the just released ePharma Physician® study by pharmaceutical and healthcare market research company Manhattan Research.
Read more ...

European researchers advance bone implants technology

Details
Research
12 August 2008
European researchers are relentless in their pursuit to develop technologies across the board. Case in point is medical technology and bone implants. Enter a team of researchers from the Germany-based Fraunhofer Institute for Manufacturing Engineering and Applied Materials Research who have developed a simulation programme calculating the internal structure and density distribution of bone material.
Read more ...

Collexis' BiomedExperts Rapidly Expanding its User Base

Details
Research
01 August 2008
Collexis Holdings Inc, (OTCBB: CLXS) a leading developer of high definition search and knowledge discovery software, announced that its premier professional scientific social networking site, Biomedexperts.com, has more than 30,000 registered users, enabling researchers across organizations and around the globe to collaborate more efficiently and effectively.
Read more ...

First call for Innovative Medicines Initiative a success

Details
Research
23 July 2008
The first stage of calls for the Innovative Medicines Initiative (IMI), which is supported by the EU with €1 billion in funding, was recently closed and is already being regarded as a success by many of those involved. From 30 April until 15 July 2008, numerous consortia of academia, small and medium-sized enterprises (SMEs), regulatory organisations and industries not affiliated with the European Federation of Pharmaceutical Industries and Associations (EFPIA) submitted their Expressions of Interest to the IMI Joint Undertaking (IMI JU) first Call for proposals.
Read more ...

More Pharma News ...

  1. New FP7 eHealth Project - preDiCT
  2. BASF and Transinsight agree to collaborate in exploring alternatives to animal testing
  3. ENCITE - European Network for Cell Imaging and Tracking Expertise
  4. EMEA recommends a new warning for epoetins for their use in cancer patients
  5. FDA Revises Process for Responding to Drug Applications
  6. The Doctor is In ... Your Inbox?
  7. Internal body signals important for diabetes research
  • Start
  • Prev
  • 294
  • 295
  • 296
  • 297
  • 298
  • 299
  • 300
  • 301
  • 302
  • 303
  • Next
  • End
Tahmeena

Business & Industry

  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
  • Acquisition of Neogene Therapeutics completed

Research & Development

  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway
  • A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
  • 500,000 missed out on blood pressure lowering drugs during pandemic

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research
  4. Treating cancer by sticking cells in place

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.